Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma

Experimental and Molecular Pathology

Volumn 80, Issue 1, 2006, Pages 72-76

  Deligezer, Ugur ^a   Erten, Nilgün ^b   Akisik, Ebru E ^a   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Caspase 3; Circulation; DNA fragmentation; DNA release; mRNA; Plasma

Indexed keywords

CASPASE 3; DNA FRAGMENT; MESSENGER RNA;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; LYMPHOCYTE; LYMPHOMA; MALE; MYELOMA; NUCLEOSOME; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

ADULT; AGED; CASPASE 3; CASPASES; DNA FRAGMENTATION; DNA, NEOPLASM; FEMALE; HODGKIN DISEASE; HUMANS; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NUCLEOSOMES; RNA, MESSENGER;

EID: 29244463339     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.05.001     Document Type: Article

References (18)

1. P. Anker Quantitative aspects of plasma/serum DNA in cancer patients Ann. N. Y. Acad. Sci. 906 2000 5 7
2. K.C. Chan, and Y.M. Lo Circulating nucleic acids as a tumor marker Histol. Histopathol. 17 2002 937 943
3. X.Q. Chen, H. Bonnefoi, M.F. Pelte, J. Lyautey, C. Lederrey, S. Movarekhi, P. Schaeffer, H.E. Mulcahy, P. Meyer, M. Stroun, and P. Anker Telomerase RNA as a detection marker in the serum of breast cancer patients Clin. Cancer Res. 6 2000 3823 3826
4. U. Deligezer, F. Yaman, N. Erten, and N. Dalay Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients Clin. Chim. Acta 335 2003 89 94
5. D.F. Dukers, J.J. Oudejans, W. Vos, R.L. ten Berge, and C.J. Meijer Apoptosis in B-cell lymphomas and reactive lymphoid tissues always involves activation of caspase 3 as determined by a new in situ detection method J. Pathol. 196 2002 307 315
6. M. Enari, H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD Nature 391 1998 43 50
7. M. Fleischhacker, T. Beinert, M. Ermitsch, D. Seferi, K. Possinger, C. Engelmann, and B. Jandrig Detection of amplifiable messenger RNA in the serum of patients with lung cancer Ann. N. Y. Acad. Sci. 945 2001 179 188
8. G.J. Fournie, J.P. Courtin, F. Laval, J.J. Chale, J.P. Pourrat, M.C. Pujazon, D. Lauque, and P. Carles Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours Cancer Lett. 9 1995 221 227
9. M.B. Giacona, G.C. Ruben, K.A. Iczkowski, T.B. Roos, D.M. Porter, and G.D. Sorenson Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls Pancreas 17 1998 89 97
10. S. Jahr, H. Hentze, S. Englisch, D. Hardt, F.O. Fackelmayer, R.D. Hesch, and R. Knippers DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res. 61 2001 1659 1665
11. R.U. Janicke, M.L. Sprengart, M.R. Wati, and A.G. Porter Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J. Biol. Chem. 273 1998 9357 9360
12. A. Maebo Plasma DNA level as a tumor marker in primary lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 28 1990 1085 1091
13. J.M. Silva, G. Dominguez, J. Silva, J.M. Garcia, A. Sanchez, O. Rodriguez, M. Provencio, P. Espana, and F. Bonilla Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics Clin. Cancer Res. 7 2001 2821 2825
14. J.M. Silva, R. Rodriguez, J.M. Garcia, C. Munoz, J. Silva, G. Dominguez, M. Provencio, P. Espana, and F. Bonilla Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells Gut 50 2002 530 534
15. G. Sozzi, D. Conte, L. Mariani, S. Lo Vullo, L. Roz, C. Lombardo, M.A. Pierotti, and L. Tavecchio Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients Cancer Res. 61 2001 4675 4678
16. N.B. Tsui, E.K. Ng, and Y.M. Lo Stability of endogenous and added RNA in blood specimens, serum, and plasma Clin. Chem. 48 2002 1647 1653
17. B.B. Wolf, M. Schuler, F. Echeverri, and D.R. Green Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation J. Biol. Chem. 274 1999 30651 30656
18. B.C. Wong, and Y.M. Lo Cell-free DNA and RNA in plasma as new tools for molecular diagnostics Expert Rev. Mol. Diagn. 3 2003 785 797